Filed with the SEC on · Summarized by InvestorsBot
IDEXX Laboratories Director Kingsley Lawrence D sold 2,203 shares of common stock on September 4 at $532.08 per share, for approximately $1,172,178. He owned 9,568 shares after the transaction.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeIDEXX reports 10% Q2 revenue growth and raises 2026 EPS outlook
8-K · August 4, 2026
IDEXX ($IDXX) filed an 8‑K (Item 9.01) disclosing a Separation Agreement (Exhibit 10.1) between Nimrata…
8-K · March 26, 2026
IDEXX ($IDXX) and Nimrata Hunt, EVP Global Strategy & Commercial, agreed she’ll cease her role Apr 13,…
8-K · March 26, 2026
IDEXX ($IDXX): Director M.
8-K · February 13, 2026
IDEXX furnished a press release titled “IDEXX Laboratories Announces Fourth Quarter and Full Year 2025…
8-K · February 2, 2026
IDEXX ($IDXX) announced financial results for the quarter and year ended Dec 31, 2025 on Feb 2, 2026.
8-K · February 2, 2026